Working alongside family planning advocates, Jhpiego Kenya applied the nine-step SMART advocacy approach to engage stakeholders in the creation of a new pharmacist training package. The updated curriculum includes that includes instruction on providing contraceptive injectables DMPA-IM and DMPA-SC.
FHI 360’s Catherine Packer shares a personal perspective on DMPA-SC’s past ten years, from early research to recent workshops. Since its introduction—and particularly since it became available for self-injection—DMPA-SC has become an important part of the global family planning and reproductive health landscape.
Recap of a webinar on high-impact approaches to support the introduction and scale-up of the self-injectable contraceptive DMPA-SC in Francophone family planning programs in Burkina Faso, Guinea, Mali, and Togo.
Providing women with containers for DMPA-subcutaneous (DMPA-SC) storage and sharps can help to encourage safe self-injection practices at home. Improper disposal in pit latrines or open spaces remains an implementation challenge to safely scaling this popular and highly effective method. With training from health providers and a provided puncture-proof container, self-injection clients enrolled in a pilot study in Ghana were able to appropriately store and dispose of DMPA-SC injectable contraceptives, offering lessons for scale-up.
Recapulatif du webinaire sur les approches à haut impact pour l’introduction et le passage à l’échelle de l'utilisation de la contraception auto-injectable.
The chronicle of Malawi’s rapid, efficient introduction of self-injected subcutaneous DMPA (DMPA-SC) into the method mix is a model of teamwork and coordination. Although this process typically takes about 10 years, Malawi achieved it in fewer than three. Self-injected DMPA-SC epitomizes the ideal of self-care by empowering women to learn how to inject themselves, and has the added benefit of helping clients avoid busy clinics during the COVID-19 pandemic.